Navigation Links
American Pacific Announces Executive Change
Date:9/17/2009

LAS VEGAS, Sept. 17 /PRNewswire-FirstCall/ -- American Pacific Corporation ("AMPAC") (Nasdaq: APFC) today announced that John R. Gibson, Chairman of the Board of Directors and Chief Executive Officer, will retire as Chief Executive Officer, effective December 31, 2009, after leading the company for over 12 years. He will be succeeded as Chief Executive Officer by Dr. Joseph Carleone, who currently serves as President and Chief Operating Officer. Mr. Gibson will retain his role as Chairman of the Board of Directors. These changes are the result of succession planning begun by the Board of Directors several years ago and are intended to provide continuity in executing AMPAC's long-term strategic plans.

Joe Carleone joined AMPAC in October, 2006, as President and Chief Operating Officer. Previously he was Senior Vice President and Chief Product Officer at Irvine Sensors Corporation, a vision systems company. Dr. Carleone was President of Aerojet Fine Chemicals LLC when AMPAC acquired the business from GenCorp Inc. in November, 2005. He had a distinguished 23 year career at Aerojet including being Vice President - Operations and Remote Sensing as well as Vice President - Armament Systems. He has published over 45 articles and edited a book entitled Tactical Missile Warheads. Dr. Carleone is a native of Philadelphia and earned his PhD in Applied Mechanics from Drexel University. He and his wife Shirley reside in Las Vegas. He is active in the community and is a member of the Executive Committee of the Nevada Development Authority, NDA.

John R. Gibson, a native of Las Vegas, became President and Chief Executive Officer in July, 1997. He joined AMPAC in 1992 after a 28 year career at U.S. Steel. Under his leadership, AMPAC has diversified into the aerospace equipment business, in 2004, and into fine chemicals, e.g. active pharmaceutical ingredients, in 2005. During his tenure corporate revenues have increased dramatically, particularly from exports and international operations.

"Joe Carleone is uniquely qualified to lead our company," commented Mr. Gibson. "He has operating and executive experience both in fine chemicals and in aerospace. The company's future is in good hands. Joe will, I'm sure, continue aggressively to pursue our current objectives, including growth and diversification."

Dr. Carleone's responsibility will be President and Chief Executive Officer. Mr. Gibson will continue to serve AMPAC as the non-executive Chairman of the Board of Directors.

ABOUT AMERICAN PACIFIC CORPORATION

American Pacific Corporation (AMPAC) is a leading custom manufacturer of fine chemicals, specialty chemicals and propulsion products within its focused markets. We supply active pharmaceutical ingredients and advanced intermediates to the pharmaceutical industry. For the aerospace and defense industry we provide specialty chemicals used in solid rocket motors for space launch and military missiles. AMPAC also designs and manufactures liquid propulsion systems, valves and structures for space and missile defense applications. We produce clean agent chemicals for the fire protection industry, as well as electro-chemical equipment for the water treatment industry. Our products are designed to meet customer specifications and often must meet certain governmental and regulatory approvals. As of August 31, 2009, AMPAC employed approximately 562 employees in nine locations, including in-space propulsion in Westcott and Cheltenham, U.K. and Dublin, Ireland. In the U.S., AMPAC has a companion in-space propulsion facility in Niagara Falls, New York, with a marketing office in Chatsworth, California. Fine chemicals are produced in Rancho Cordova, California. The specialty chemicals segment is located in Cedar City, Utah. Las Vegas remains as the corporate headquarters. Additional information about us can be obtained by visiting our web site at www.apfc.com.


'/>"/>
SOURCE American Pacific Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Trust for Americas Health Applauds HHS Announcement of Prevention and Wellness Fund of the American Recovery and Reinvestment Act
2. Capital Gold Group Donates to American Red Cross Disaster Relief for Victims of Southern California Wildfires
3. Fifty-Four Percent of Americans Believe Health Care Reform Will Not Be Passed This Year
4. Health Care Reform and American Federalism
5. Older Americans: How they are faring in the recession
6. Anthem Blue Cross and Blue Shield Foundation Grant Supporting American Diabetes Associations Family Link Program In Connecticut
7. Leading American Healthcare Experts Press Congress to Act Quickly on Health Reform
8. African Americans at Significantly Higher Risk of DVT or Blood Clots
9. Prescient Medical vProtect(TM) Luminal Shield Receives North American Product Innovation of the Year Award from Frost & Sullivan
10. Dakim BrainFitness Receives First Company-Wide Adoption in Wisconsin at All Seven AmericanWay Senior Living Homes
11. American Jews to Protest Against Hadassah Hospital
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... March 28, 2017 , ... Z-Medica, ... University of Pittsburgh Medical Center (UPMC) will acquire QuikClot® Bleeding Control Kits® (BCK) ... program, developed in association with efforts by the American College of Surgeons, U.S. ...
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... ... laboratory instruments are critical to ensuring high-quality results and maintaining GMP and USP ... of Laboratory Instruments in accordance with GMP requirements " these requirements are explained. ...
(Date:3/28/2017)... ... 28, 2017 , ... With less than 10,000 dermatologists in the United States ... be limited while the desire to conquer breakouts and eliminate skincare stress is widespread. ... customer online, today released its inaugural survey on the State of Acne in America. ...
(Date:3/28/2017)... ... , ... Columbus OH. Dr. Justin Harper, Founder of Juvly Aesthetics in Ohio ... country to sit on the 2017 National Advisory Board for Allergan’s Facial Aesthetics National ... helped propel the clinic from a small start-up to number 78 in the country ...
(Date:3/28/2017)... ... March 28, 2017 , ... Public relations pros work hard to ... of business channels. , While many results are clear, much of PR is hard ... , When it comes to measurement, firms should always take an all-inclusive approach that ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... Mass. , March 28, 2017 ... company developing innovative therapeutics that address significant unmet ... a patent from the Japan Patent Office (JPO) ... connective tissue growth factor (CTGF) for the treatment ... limited to skin fibrosis and proliferative retinopathy (Japanese ...
(Date:3/28/2017)... , March 28, 2017 ... research with Cambridge ... Consortium   The Milner Therapeutics Institute today announces ... Elysium Health has committed significant investment for collaborative projects with ... next four years. This is the first major research investment ...
(Date:3/27/2017)... TEL-AVIV, Israel , March 27, 2017 /PRNewswire/ ... TASE: THXBY), a specialty clinical-stage pharmaceutical company specializing in the ... of its public offering in the ... Shares (ADSs), each ADS representing 40 ordinary shares ... per ADS. In addition, Therapix has granted the ...
Breaking Medicine Technology: